Loading chart…
PRE-MARKET
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant.
Rubicon Research Limited (RUBICON) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The RUBICON share price is ₹1,717.30 (-0.21% today), with a market capitalisation of ₹284B and a price-to-earnings (P/E) ratio of 88.1. MarketRipple tracks the RUBICON investment thesis, the ripple-chain impact of market events on Rubicon Research Limited, and the Healthcare sector outlook.
Open
₹1,723.30
High
₹1,746.90
Low
₹1,704.10
Prev. Close
₹1,721.00
52W High
₹1,899.00
52W Low
₹609.25
Day range
₹1,704.10–₹1,746.90
52-week range
₹609.25–₹1,899.00
Volume
69K
P/E
88.1
ROE
31.3%
D/E
0.24
Margin
15.5%
Rubicon Research Limited (NSE: RUBICON) is currently trading at ₹1,717.30 (-0.21%).
Rubicon Research Limited's market capitalization is ₹284B.
Rubicon Research Limited's price-to-earnings (P/E) ratio is 88.1.
Rubicon Research Limited operates in the Healthcare sector (Drug Manufacturers - General).
Analyst consensus on Rubicon Research Limited currently reads strongly positive, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.